Age-related difference in synaptosomal membrane
fluidity
Hiroyuki Ohyama, Midori Hiramatsu, Norio
Ogawa, Akitane Mori
Biochemistry and Molecular Biology International
37,133-140,1995
Department of Neuroscience, Institute of
Molecular and Cellular Medicine, Okayama
University Medical School,
2-5-1 Shikatacho, Okayama 700, Japan
and *Division of Medical Science, Institute
for Life Support Technology, Yamagata Technopolis
Foundation,
Yamagata 683 Kurumanomae, Numagi, Yamagata
990, Japan
ACKNOWLEDGEMENTS
We thank Dr. Lester Packer of the University of California, Berkeley,
for reading our manuscript and providing us with valuable comments.
Special Thanks.
Dr. Lester Packer
Building 20 - 251 LSA
Energy & Environment Division
Lawrence Berkeley Laboratory
University of California
Berkeley, CA 94720
The SAM Model of Senescence(T.Takeda,ed.)
pp.343-346,
Elsevier Science B.V.,Amsterdam,1994
8)
Mixed Natural Antioxidants
Hiramatsu,M.
Food and Free Radicals,edited by Hiramatsu
et al.
Plenum Press,New York,pp.113-117,1997
References １
(1) Whitehouse P.J., Price D.L. and Struble
R.G. Alzheimer's disease and senile dimentia:
loss of neurons in the basal forebrain. Science
215, 1237-1239, 1982.
(2) Price D.L., Whitehouse P.J. and Struble
R.G. Alzheimer's diseases. Ann. Rev. Med.
36, 349-356, 1985.
(3) Appleyard M.E., Smith A.D., Wilcock G.K
and Esiri M.M. Decreased CSF acetylcholinesterase
activity in Alzheimer's disease. Lancet 20,
452, 1983
(4) Lovell M.A., Ehmann W.D., Butler S.M.
and Markesbery W.R. Elevated thiobarbituric
acid reactive substances and antioxident
enzyme activity in the brain in Alzheimer's
disease. Neurology 45, 1594-1601, 1995.
(5)Mutisya E.M., Bowling A.B. and Beal M.F.
Cortical cytochrome oxidase activity is reduced
in Alzheimer's disease. J. Neurochem. 63,
2179-2184, 1994.
(6) Hensley K., Carney J.M., Mattson M.P.,
Aksenova M., Harris M., Wu J.F. and Floud
R.A. A model for α-amyloid aggregation and
neurotoxicity based on free radical generation
by the peptide: Relevance to Alzheimer disease.
Proc. Natl. Acad. Sci. USA 91, 3270-3274,
1994.
(7) Kasai H. and Nishimura S. Hydroxylation
of deoxyguanosine at the C-8 position by
ascorbic acid and other reducing agents.
Nucleic Acids Res. 12, 2137-2145, 1984.
(8) Shibutani S., Takeshita M. and Grollman
A.P. Insertion of specific nases during DNA
synthesis past the oxidation damage base
8-oxodG. Nature 349, 431-434, 1991.
(9) Cheng K.C., Cahill D.S., Kasai H., Nishimura
S. and Loeb L.A. 8-Hydroxyguanine, an abundant
form of oxidative DNA damage, causes G→T
and A→C substitutions. J. Biol. Chem. 267,
166-172, 1992.
(10) Prasad G.S., Lovell M.A. and Markesbery
W.R. Increased nuclear DNA oxidation in the
brain in Alzheimer's diseases. J. Neurochem.
71, 2034-2040, 1998.
(11) Sohal R.S., Agarwal S. and Sohal B.H.
Oxidative stress and aging in the Mongolian
gerbil (Meriones unquiculatus). Mech. Ageing
and Dev. 81, 15-25, 1995.
(12) Asuncion J.G., Millan A., Pla R., Bruseghini
L, Esteras A., Pallardo F.V., Sastre J. and
Vina J. Mitochondrial glutathione oxidation
correlates with age-associated oxidative
damage to mitochondrial DNA. FASEB J. 10,
333-338, 1996.
(13) Sastre J., Millan A., Asuncion J.G.,
Pla R., Juan G., Pallardo F., O'Conner E.,
Martin J.A., Droy-Refaix M.T. and Vina J.
A Ginkgo biloba extract (EGb 761) prevents
mitochondrial aging by protecting against
oxidative stress. Free Rad. Biol. Med. 24,
298-304, 1998.
(14) Mecocci P., Fano G., Fulle S., MacGarvey
U., Shinobu L., Polidori M.C., Cherubini
A., Vecchiet J., Senin U. and Beal M.F. Age-dependent
increases in oxidative damage to DNA, lipids,
and proteins in human skeletal muscle. Free
Rad. Biol. Med. 26, 303-308, 1999.
(15) Ciani E., Groneng L., Voltattorni M.,
et al. Inhibition of free radical production
or free radical scavenging protects from
the excitotoxic cell death mediated by glutamate
in cultures of cerebellar granule neurons.,
Brain Res. 728, 1-6, 1996.
(16) Dawson V.L. and Dawson T.M. Free radicals
and neuronal cell death. Cell Death and Differentiation
3, 71-78, 1996.
(17) Pillot T., Drouet B., Queille S., Labeur
C., Vandekerckhove J., Rosseneu M., Pincon-Raymond
M. and Chambaz J. The nonfibrillar amyloid
_-peptide induces apoptotic neuronal cell
death: Involvement of its c-terminal fusogenic
domain. J. Neurochem. 73, 1626-1634, 1999.
(18) Herbison A.E., Augood S.J. and Slmonian
S.X. Regulation of GABA transport activity
and mRNA expression by estrogen in rat preoptic
ares. J. Neurosci. 15, 8302-8309, 1995.
References 2
1. Chartier-Harlin,M.C. et al. Early-onset
Alzheimer's disease caused bymutations at
codon precursor protein gene. Nature 353,
844-846 (1991).
2. Sherrington,R.et al. Cloning of a gene
bearing missense mutations inearly-onset
familial Alzheimer's disease. Nature 375,
754-760 (1995).
3. Rogaev,E.I. et al. Familial Alzheimer's
disease in kindreds withmissense mutations
in a gene on chromosome 1 related to the
Alzheimer'sdisease type 3 gene. Nature 376,
775-778 (1995).
4. Borchelt,D.R. et al. Familial Alzheimer's
disease-linked presenilin 1variants elevate
Abeta1-42/1-40 ratio in vitro and in vivo.
Neuron 17,1005-1013 (1996).
5. Duff,K. et al. Increased amyloid beta42
(43) in brains of miceexpressing mutant presenilin
1. Nature 383, 710-713 (1996).
6. Nakano,Y.et al. Accumulation of murine
amyloid beta42 with a gene-dosagedependent
manner in PS1 'knock-in' mice. Eur.J.Neurosci.
11, 2577-2581(1999).
7. Iwatsubo,T. et al. Visualization of A?42
(43) and A?40 in senileplaques with end-specific
A monoclonals: evidence that an initiallydeposited
species is A?42 (43). Neuron 13, 45-53 (1994).
8. Scheuner,D. et al. Secreted amyloid beta-protein
similar to that in thesenile plaques of Alzheimer's
disease is increased in vivo by thepresenilin
a and 2 and APP mutations linked to familial
Alzheimer'sdisease. Nature Med. 2, 864-870
(1996).
9. Wong,P.C. et al. Presenilin 1 is required
for Notch and Dll1 expressionin the paraxial
mesoderm. Nature 387, 288-292 (1997).
10. Davis,J.A. et al. An Alzheimer's disease-linked
PS1 variant rescues thedevelopmental abnormalities
of PS1-deficient embryos. Neuron 20, 603-609(1998).
11. De Strooper,B. et al. Deficiency of presenilin-1
inhibits the normalcleavage of amyloid precursor
protein. Nature 391, 387-390 (1998).
12. Wolfe,M.S. et al. Two transmembrane aspartates
in presenilin-1required for presenilin endoproteolysis
and gamma-secretase activity.Nature 398,
513-517 (1999).
13. Guo,Q.et al. Alzheimer's presenilin mutation
sensitizes neural cells toapoptosis induced
by trophic factor withdrawal and amyloid
peptide:involvement of calcium and oxyradicals.
J.Neurosci. 17, 4212-4222 (1997).
14. Guo,Q.et al. Increased vulnerability
of hippocampal neurons toexcitotoxic necrosis
in presenilin-1 mutant knock-in mice. Nature
Med. 5,101-106 (1999).
15. Sidrauski,C.et al. The unfolded protein
response: an intracellularsignalling pathway
with many surprising features. Trends in
Cell Biol. 8,245-249 (1998).
16. Tirasophon,W. et al. A stress response
pathway from the endoplasmicreticulum to
the nucleus requires a novel bifunctional
proteinkinase/endoribonuclease (Ire1p) in
mammalian cells. Genes Dev. 12,1812-1824(1998).
17. Wang,X-Z.et al. Cloning of mammalian
Ire1 reveals diversity in the ERstress responses.
EMBO J. 17, 5708-5717 (1998).
18. Katayama, T. et al. Presenilin-1 mutations
downregulate the signalling pathway of unfolded
protein response. Nature Cell Biol. in press
(1999).
19. Iwatsubo, T. et al. Purification and
characterization of Lewy bodiesfrom the brains
of patients with diffuse Lewy body disease.
Am.J.Pathol.148, 1517-1529 (1996).
20. DiFiglia,M. et al. Aggregation of huntingtin
in neuronal intranuclearinclusions and dystrophic
neurites in brain. Science 277, 1990-1993(1997).
in 1998.
